Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?

Detalles Bibliográficos
Autor principal: Daizadeh, Iraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579901/
https://www.ncbi.nlm.nih.gov/pubmed/33090367
http://dx.doi.org/10.1007/s43441-020-00233-0
_version_ 1783598687414386688
author Daizadeh, Iraj
author_facet Daizadeh, Iraj
author_sort Daizadeh, Iraj
collection PubMed
description
format Online
Article
Text
id pubmed-7579901
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-75799012020-10-23 Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness? Daizadeh, Iraj Ther Innov Regul Sci Commentary Springer International Publishing 2020-10-22 2021 /pmc/articles/PMC7579901/ /pubmed/33090367 http://dx.doi.org/10.1007/s43441-020-00233-0 Text en © The Drug Information Association, Inc 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Commentary
Daizadeh, Iraj
Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
title Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
title_full Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
title_fullStr Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
title_full_unstemmed Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
title_short Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
title_sort since the mid-2010s fda drug and biologic guidelines have been growing at a faster clip than prior years: is it time to analyze their effectiveness?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579901/
https://www.ncbi.nlm.nih.gov/pubmed/33090367
http://dx.doi.org/10.1007/s43441-020-00233-0
work_keys_str_mv AT daizadehiraj sincethemid2010sfdadrugandbiologicguidelineshavebeengrowingatafasterclipthanprioryearsisittimetoanalyzetheireffectiveness

Ejemplares similares